RxDoctor Payments Data

Stephen Riutta, MD

Anesthesiology · Ypsilanti, MINPI 1114422144

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (58.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Boston Scientific at 59.0% of the total. Reporting peaked in 2022 at $6,947 and has fallen 97.9% since, to $144 in 2025. Among anesthesiology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,736in general payments, 2019–2025

Across 41 payments — averaging $213.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$5K
  • Medtronic$3K
  • Abbott$172
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$160
  • Nevro Corp.$125
  • SPR Therapeutics, Inc$103

What the payments were for

  • Grants$5,09458%
  • Travel & lodging$1,45517%
  • Food & beverage$2,18725%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,736 in reported general payments places this provider in the 95th percentile of 1,299 anesthesiology providers in Michigan.

See all anesthesiology providers in Michigan

Medicare billing

Part B allowed, 2024
$50,839
Medicare patients
203
Services billed
495

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin26$430

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Ypsilanti

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →